每周股票复盘：心脉医疗（688016）拟用10亿闲置募资做现金管理

Core Viewpoint - The company plans to utilize up to 1 billion RMB of temporarily idle raised funds for cash management, focusing on high safety and liquidity investment products [1][2] Company Announcement Summary - As of January 23, 2026, the stock price of Xinmai Medical (688016) closed at 98.1 RMB, a slight increase of 0.12% from the previous week [1] - The company reported a total market capitalization of 12.092 billion RMB, ranking 30th out of 127 in the medical device sector and 1779th out of 5182 in the A-share market [1] - The board of directors approved the use of idle funds for cash management, with a focus on structured deposits, notice deposits, time deposits, large certificates of deposit, and income certificates, with a rolling usage period of 12 months [1] - The company assures that this decision will not affect the normal implementation of the fundraising investment plan, and the earnings will be used to supplement funding shortages for investment projects and daily operational liquidity [1][2] Regulatory Review Summary - China International Capital Corporation (CICC) has reviewed the company's plan to use up to 1 billion RMB of temporarily idle funds for cash management, confirming that it does not alter the intended use of the raised funds [2] - The review indicates that the decision will enhance fund utilization efficiency without harming the interests of the company and its shareholders [2]